InvestorsHub Logo
Followers 0
Posts 1444
Boards Moderated 0
Alias Born 03/19/2012

Re: None

Friday, 07/05/2013 10:29:10 AM

Friday, July 05, 2013 10:29:10 AM

Post# of 401907
IMO the FDA approves or fast tracks 12hr ER ELI216 Oxy/Nal as a 505b2 NDA based on its CY2013 Human Pilot Studies BEs & PKs patented delivery results vs.

(1) 12hr ER ADT Purdue Oxycontin

(2) 12hr ER ART Pfizer ALO-01 Mor/Nal

(3) 12hr ER ART Pfizer ALO-02 Oxy/Nal
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News